Reproductive Aging in Men

Endocrinology and Metabolism Clinics of North America

Volumn 42, Issue 2, 2013, Pages 255-270

  Basaria, Shehzad ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Androgen deficiency; Andropause; Frailty; Late onset hypogonadism; Sexual dysfunction

Indexed keywords

ANDROSTANOLONE; CHORIONIC GONADOTROPIN; LUTEINIZING HORMONE; OPIATE DERIVATIVE; PRASTERONE; PRASTERONE SULFATE; SPIRONOLACTONE; TESTOSTERONE;

AGING; ANDROGEN DEFICIENCY; BODY COMPOSITION; BONE DENSITY; BONE DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EVALUATION; COGNITIVE DEFECT; COMORBIDITY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE COURSE; ERECTILE DYSFUNCTION; HEART DISEASE; HEART FAILURE; HORMONE ACTION; HUMAN; HYPOGONADISM; KIDNEY DISEASE; LEYDIG CELL; MASS SCREENING; METABOLIC DISORDER; NEUROENDOCRINE DISEASE; OBESITY; PATHOPHYSIOLOGY; PHYSICAL CAPACITY; PHYSICAL DISABILITY; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEXUAL FUNCTION; SYMPTOM; TESTOSTERONE BLOOD LEVEL;

AGING; ANDROGENS; ANDROPAUSE; ANIMALS; HUMANS; HYPOGONADISM; MALE; NEUROSECRETORY SYSTEMS; REPRODUCTIVE HEALTH; TESTIS;

EID: 84878125519     PISSN: 08898529     EISSN: 15584410     Source Type: Journal    
DOI: 10.1016/j.ecl.2013.02.012     Document Type: Review

References (91)

1. Basaria S., Wahlstrom J.T., Dobs A.S. Anabolic-androgenic steroid therapy in the treatment of chronic diseases. J Clin Endocrinol Metab 2001, 86:5108-5117.
2. Brown-Sequard C.E. Note on the effects produced on man by subcutaneous injections of a liquid obtained from the testicles of animals. Lancet 1889, 2:105-107.
3. Freeman E.R., Bloom D.A., McGuire E.J. A brief history of testosterone. J Urol 2001, 165:371-373.
4. Handelsman D.J. Trends and regional differences in testosterone prescribing in Australia, 1991-2001. Med J Aust 2004, 181:419-422.
5. Bhasin S., Cunningham G.R., Hayes F.J., et al. Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2010, 95:2536-2559.
6. Wang C., Nieschlag E., Swerdloff R., et al. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol 2008, 159:507-514.
7. Hammond G.L., Ruokonen A., Kontturi M., et al. Simultaneous radioimmunoassay of 7 steroids in human spermatic and peripheral venous-blood. J Clin Endocrinol Metab 1977, 45:16-24.
8. Horton R., Tait J. The in vivo conversion of dehydroisoandrosterone to plasma androstenedione and testosterone. J Clin Endocrinol Metab 1967, 27:79.
9. Dunn J.F., Nisula B.C., Rodbard D. Transport of steroid-hormones-binding of 21 endogenous steroids to both testosterone binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab 1981, 53:58-68.
10. Chan L., O'Malley B.W. Mechanism of action of the sex steroid hormones. N Engl J Med 1976, 294:1322-1328.
11. Pardridge W.M. Serum bioavailability of sex steroid hormones. Clin Endocrinol Metab 1986, 15:259-278.
12. Vermeulen A. Androgen replacement therapy in the aging male. A critical evaluation. J Clin Endocrinol Metab 2001, 86:2380-2390.
13. Bremner W.J., Vitiello M.V., Prinz P.N. Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metab 1983, 56:1278-1281.
14. Hollander N., Hollander V.P. The microdetermination of testosterone in human spermatic vein blood. J Clin Endocrinol Metab 1958, 19:966-970.
15. Harman S.M., Metter E.J., Tobin J.D., et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001, 86:724-731.
16. Feldman H.A., Longcope C., Derby C.A., et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 2002, 87:589-598.
17. Ferrini R.L., Barrett-Connor E. Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. Am J Epidemiol 1998, 147:750-754.
18. Wu F.C., Tajar A., Pye S.R., et al. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab 2008, 93:2737-2745.
19. Giusti G., Gonnelli P., Borrelli D., et al. Age-related secretion of androstenedione, testosterone and dihydrotestosterone by human testis. Exp Gerontol 1975, 10:241-245.
20. Vermeulen A., Verdonck L., Rubens R. Testosterone secretion and metabolism in male senescence. J Clin Endocrinol Metab 1972, 34:730-735.
21. Travison T.G., Araujo A.B., Kupelian V., et al. The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. J Clin Endocrinol Metab 2007, 92:549-555.
22. Tajar A., Forti G., O'Neill T.W., et al. Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. J Clin Endocrinol Metab 2010, 95:1810-1818.
23. Wu F.C., Tajar A., Beynon J.M., et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 2010, 363:123-135.
24. Mahmoud A.M., Goemaere S., El-Garem Y., et al. Testicular volume in relation to hormonal indices of gonadal function in community-dwelling elderly men. J Clin Endocrinol Metab 2003, 88:179-184.
25. Kidd S.A., Eskenazi B., Wyrobek A.J. Effects of male age on semen quality and fertility: a review of the literature. Fertil Steril 2001, 75:237-248.
26. Araujo A.B., Esche G.R., Kupelian V., et al. Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab 2007, 92:4241-4247.
27. Handelsman D.J., Dong Q. Hypothalamo-pituitary gonadal axis in chronic renal failure. Endocrinol Metab Clin North Am 1993, 22:145-161.
28. Jankowska E.A., Biel B., Majda J., et al. Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival. Circulation 2006, 114:1829-1837.
29. Sartorius G., Spasevska S., Idan A., et al. Serum testosterone, dihydrotestosterone and estradiol concentrations in older men self-reporting very good health: the healthy man study. Clin Endocrinol (Oxf) 2012, 77:755-763.
30. Travison T.G., Araujo A.B., O'Donnell A.B., et al. A population-level decline in serum testosterone levels in American men. J Clin Endocrinol Metab 2007, 92:196-202.
31. Andersson A.M., Jensen T.K., Juul A., et al. Secular decline in male testosterone and sex hormone binding globulin serum levels in Danish population surveys. J Clin Endocrinol Metab 2007, 92:4696-4705.
32. Vermeulen A. Androgens in the aging male. J Clin Endocrinol Metab 1991, 73:221-224.
33. Neaves W.B., Johnson L., Porter J.C., et al. Leydig cell numbers, daily sperm production, and serum gonadotropin levels in aging men. J Clin Endocrinol Metab 1984, 59:756-763.
34. Neaves W.B., Johnson L., Petty C.S. Age-related change in numbers of other interstitial cells in testes of adult men. Evidence bearing on the fate of Leydig cells lost with increasing age. Biol Reprod 1985, 33:259-269.
35. Rubens R., Dhont M., Vermeule A. Further studies on Leydig cell function in old-age. J Clin Endocrinol Metab 1974, 39:40-45.
36. Longcope C. Effect of human chorionic gonadotropin on plasma steroid levels in young and old men. Steroids 1973, 21:583-590.
37. Nankin H.R., Lin T., Murono E.P., et al. The aging Leydig cell. Gonadotropin stimulation in men. J Androl 1981, 2:181-189.
38. Mahmoud A.M., Goemaere S., De Bacquer D., et al. Serum inhibin B levels in community-dwelling elderly men. Clin Endocrinol (Oxf) 2000, 53:141-147.
39. Urban R.J., Veldhuis J.D., Blizzard R.M., et al. Attenuated release of biologically active luteinizing hormone in healthy aging men. J Clin Invest 1988, 81:1020-1029.
40. Pincus S.M., Veldhuis J.D., Mulligan T., et al. Effects of age on the irregularity of LH and FSH serum concentrations in women and men. Am J Physiol 1997, 273:E989-E995.
41. Mulligan T., Iranmanesh A., Kerzner R., et al. Two-week pulsatile gonadotropin releasing hormone infusion unmasks dual (hypothalamic and Leydig cell) defects in the healthy aging male gonadotropic axis. Eur J Endocrinol 1999, 141:257-266.
42. Kaufman J.M., Giri M., Deslypere J.M., et al. Influence of age on the responsiveness of the gonadotrophs to luteinizing-hormone-releasing hormone in males. J Clin Endocrinol Metab 1991, 72:1255-1260.
43. Veldhuis J.D., Urban R.J., Lizarralde G., et al. Attenuation of luteinizing hormone secretory burst amplitude as a proximate basis for the hypoandrogenism of healthy aging in men. J Clin Endocrinol Metab 1992, 75:707-713.
44. Bonavera J.J., Swerdloff R.S., Sinha Hakim A.P., et al. Aging results in attenuated gonadotropin releasing hormone-luteinizing hormone axis responsiveness to glutamate receptor agonist N-methyl-D-aspartate. J Neuroendocrinol 1998, 10:93-99.
45. Winters S.J., Sherins R.J., Troen P. The gonadotropin-suppressive activity of androgen is increased in elderly men. Metabolism 1984, 33:1052-1059.
46. Winters S.J., Atkinson L. Serum LH concentrations in hypogonadal men during transdermal testosterone replacement through scrotal skin: further evidence that ageing enhances testosterone negative feedback. Clin Endocrinol (Oxf) 1997, 47:317-322.
47. Araujo A.B., O'Donnell A.B., Brambilla D.J., et al. Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 2004, 89:5920-5926.
48. Diver M.J., Imtiaz K.E., Ahmad A.M., et al. Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men. Clin Endocrinol (Oxf) 2003, 58:710-717.
49. Brambilla D.J., Matsumoto A.M., Araujo A.B., et al. The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men. J Clin Endocrinol Metab 2009, 94:907-913.
50. Zitzmann M., Faber S., Nieschlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 2006, 91:4335-4343.
51. Kelleher S., Conway A.J., Handelsman D.J. Blood testosterone threshold for androgen deficiency symptoms. J Clin Endocrinol Metab 2004, 89:3813-3817.
52. Manni A., Pardridge W.M., Cefalu W., et al. Bioavailability of albumin-bound testosterone. J Clin Endocrinol Metab 1985, 61:705-771.
53. Vermeulen A., Verdonck L., Kaufman J.M. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999, 84:3666-3672.
54. Mazer N.A. A novel spreadsheet method for calculating the free serum concentrations of testosterone, dihydrotestosterone, estradiol, estrone and cortisol: with illustrative examples from male and female populations. Steroids 2009, 74:512-519.
55. Winters S.J., Kelley D.E., Goodpaster B. The analog free testosterone assay: are the results in men clinically useful?. Clin Chem 1998, 44:2178-2182.
56. Vermeulen A., Kaufman J.M., Giagulli V.A. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. J Clin Endocrinol Metab 1996, 81:1821-1826.
57. Glass A.R., Swerdloff R.S., Bray G.A., et al. Low serum testosterone and sex-hormone-binding-globulin in massively obese men. J Clin Endocrinol Metab 1977, 45:1211-1219.
58. Morley J.E., Charlton E., Patrick P., et al. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism 2000, 49:1239-1242.
59. Smith K.W., Feldman H.A., McKinlay J.B. Construction and field validation of a self-administered screener for testosterone deficiency (hypogonadism) in ageing men. Clin Endocrinol (Oxf) 2000, 53:703-711.
60. Moore C., Huebler D., Zimmermann T., et al. The Aging Males' Symptoms scale (AMS) as outcome measure for treatment of androgen deficiency. Eur Urol 2004, 46:80-87.
61. Rosen R.C., Araujo A.B., Connor M.K., et al. The NERI Hypogonadism Screener: psychometric validation in male patients and controls. Clin Endocrinol (Oxf) 2011, 74:248-256.
62. Travison T.G., Morley J.E., Araujo A.B., et al. The relationship between libido and testosterone levels in aging men. J Clin Endocrinol Metab 2006, 91:2509-2513.
63. Korenman S.G., Morley J.E., Mooradian A.D., et al. Secondary hypogonadism in older men: its relation to impotence. J Clin Endocrinol Metab 1990, 71:963-969.
64. Orwoll E., Lambert L.C., Marshall L.M., et al. Endogenous testosterone levels, physical performance, and fall risk in older men. Arch Intern Med 2006, 166:2124-2131.
65. Cawthon P.M., Ensrud K.E., Laughlin G.A., et al. Sex hormones and frailty in older men: the osteoporotic fractures in men (MrOS) study. J Clin Endocrinol Metab 2009, 94:3806-3815.
66. Krasnoff J.B., Basaria S., Pencina M.J., et al. Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Offspring Study. J Clin Endocrinol Metab 2010, 95:2790-2799.
67. Roy T.A., Blackman M.R., Harman S.M., et al. Interrelationships of serum testosterone and free testosterone index with FFM and strength in aging men. Am J Physiol Endocrinol Metab 2002, 283:E284-E294.
68. Hier D.B., Crowley W.F. Spatial ability in androgen-deficient men. N Engl J Med 1982, 306:1202-1205.
69. Janowsky J.S., Oviatt S.K., Orwoll E.S. Testosterone influences spatial cognition in older men. Behav Neurosci 1994, 108:325-332.
70. Alexander G.M., Swerdloff R.S., Wang C., et al. Androgen-behavior correlations in hypogonadal men and eugonadal men. II. Cognitive abilities. Horm Behav 1998, 33:85-94.
71. Moffat S.D., Zonderman A.B., Metter E.J., et al. Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J Clin Endocrinol Metab 2002, 87:5001-5007.
72. Moffat S.D., Resnick S.M. Long-term measures of free testosterone predict regional cerebral blood flow patterns in elderly men. Neurobiol Aging 2007, 28:914-920.
73. Barrett-Conner E., Von Muhlen D.G., Kritz-Silverstein D. Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo study. J Clin Endocrinol Metab 1999, 84:573-577.
74. Seidman S.N., Araujo A.B., Roose S.P., et al. Testosterone level, androgen receptor polymorphism, and depressive symptoms in middle-aged men. Biol Psychiatry 2001, 50:371-376.
75. Seidman S.N., Araujo A.B., Roose S.P., et al. Low testosterone levels in elderly men with dysthymic disorder. Am J Psychiatry 2002, 159:456-459.
76. Greendale G.A., Edelstein S., Barrett-Connor E. Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study. J Bone Miner Res 1997, 12:1833-1843.
77. Khosla S., Melton L.J., Robb R.A., et al. Relationship of volumetric BMD and structural parameters at different skeletal sites to sex steroid levels in men. J Bone Miner Res 2005, 20:730-740.
78. Benito M., Vasilic B., Wehrli F.W., et al. Effect of testosterone replacement on trabecular architecture in hypogonadal men. J Bone Miner Res 2005, 20:1785-1791.
79. Mellstrom D., Johnell O., Ljunggren O., et al. Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden. J Bone Miner Res 2006, 21:529-535.
80. Fink H.A., Ewing S.K., Ensrud K.E., et al. Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men. J Clin Endocrinol Metab 2006, 91:3908-3915.
81. Khosla S., Melton L.J., Atkinson E.J., et al. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab 1998, 83:2266-2274.
82. Ding E.L., Song Y., Malik V.S., et al. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2006, 295:1288-1299.
83. Brand J.S., van der Tweel I., Grobbee D.E., et al. Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies. Int J Epidemiol 2011, 40:189-207.
84. Lakshman K.M., Bhasin S., Araujo A.B. Sex hormone-binding globulin as an independent predictor of incident type 2 diabetes mellitus in men. J Gerontol A Biol Sci Med Sci 2010, 65:503-509.
85. Wu F.C., von Eckardstein A. Androgens and coronary artery disease. Endocr Rev 2003, 24:183-217.
86. Barrett-Connor E., Khaw K.T. Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. Circulation 1988, 78:539-545.
87. Shores M.M., Matsumoto A.M., Sloan K.L., et al. Low serum testosterone and mortality in male veterans. Arch Intern Med 2006, 166:1660-1665.
88. Araujo A.B., Kupelian V., Page S.T., et al. Sex steroids and all-cause and cause-specific mortality in men. Arch Intern Med 2007, 167:1252-1260.
89. Laughlin G.A., Barrett-Connor E., Bergstrom J. Low serum testosterone and mortality in older men. J Clin Endocrinol Metab 2008, 93:68-75.
90. Tajar A., Huhtaniemi I.T., O'Neill T.W., et al. Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS). J Clin Endocrinol Metab 2012, 97:1508-1516.
91. Hammoud A., Gibson M., Hunt S.C., et al. Effect of Roux-en-Y gastric bypass surgery on the sex steroids and quality of life in obese men. J Clin Endocrinol Metab 2009, 94:1329-1332.